the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Plytec records RM45.6 million revenue for Q3FYE2023

KUALA LUMPUR: Construction engineering solutions and services as well as trading and distribution of building materials company, Plytec Holding Berhad, in announcing its third quarter results for the financial year ending Dec 31, 2023 (Q3FYE2023), recorded an unaudited profit before tax (PBT) and profit after tax (PAT) of RM6.2 million and RM4.4 million respectively on the back of a RM45.6 million revenue.

For the cumulative 9-month period ended Sept 30, 2023, the unaudited revenue, PBT and PAT were RM123.1 million, RM12.9 million and RM9.6 million respectively.

Plytec’s domestic clients accounted for approximately RM119.9 million whereas its overseas clients from Singapore and Thailand contributed RM3.2 million in revenue.

Plytec is scheduled to be listed on the ACE Market of Bursa Malaysia Securities Berhad on Nov 15, 2023.

Plytec Group managing director/CEO Yang Kian Lock said, “We are pleased with our financial results for the third quarter of 2023. Thus far in 2023, we have made significant capital expenditure to expand our rental assets portfolio and focus on our digital design and engineering segment, as we anticipate these endeavours to contribute positively to our financial performance in the future. The team has worked relentlessly to continuously secure new customers, with a notable addition of the Sarawak Economic Development Corporation for setting up a digital ecosystem in Sarawak to facilitate the digital transformation of the state into a smart city.”

Furthermore, he added Plytec also recently expanded its presence into Hungary in Europe.

“We are confident that we will be able to elevate Plytec to greater heights and are capable of reflecting even better financials in the future,” he said

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings